Search by Drug Name or NDC

    NDC 64896-0078-09 LYVISPAH 20 mg/1 Details

    LYVISPAH 20 mg/1

    LYVISPAH is a ORAL GRANULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is BACLOFEN.

    Product Information

    NDC 64896-0078
    Product ID 64896-078_c74519bf-2f00-4790-a3aa-80aecadbca94
    Associated GPIs
    GCN Sequence Number 082878
    GCN Sequence Number Description baclofen GRAN PACK 20 MG ORAL
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 51652
    HICL Sequence Number 001949
    HICL Sequence Number Description BACLOFEN
    Brand/Generic Brand
    Proprietary Name LYVISPAH
    Proprietary Name Suffix n/a
    Non-Proprietary Name baclofen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GRANULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name BACLOFEN
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215422
    Listing Certified Through 2024-12-31

    Package

    NDC 64896-0078-09 (64896007809)

    NDC Package Code 64896-078-09
    Billing NDC 64896007809
    Package 90 PACKET in 1 CARTON (64896-078-09) / 1 GRANULE in 1 PACKET
    Marketing Start Date 2023-06-01
    NDC Exclude Flag N
    Pricing Information N/A